In the 72-week SURMOUNT-5 trial described in this article, average weight reduction was 20.2% with tirzepatide and 13.7% with semaglutide among adults with obesity without type 2 diabetes
Most women do not need perfection
The following week, a small gain appears on the scale
BPC 157 , a synthetic peptide, has emerged as a subject of growing interest in the UK athletic community
The popular weight-loss drug Wegovy, which has helped millions of Americans shed pounds, can be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have obesity, federal regulators said in March.
doi:10.1111/dom.15292 Pasternak B, Wintzell V, Hviid A, Eliasson B, Gudbjrnsdottir S, Jonasson C, et al